The Coliseum site, operated in partnership between the state's Office of Emergency Services and the Federal Emergency Management Agency, and the Department of Defense, is part...
If you’re eligible and vaccine appointments are available through My Turn, you can schedule one.
“Many African Americans are making a mistake thinking the vaccine is not good for them,” he said. “The vaccines of the past worked because so many...
Last week, I had the opportunity to meet and interview Dr. Mark Finch on the Health Beat TV show on Channel 78. , Highly experienced and...
Nine months into the COVID-19 pandemic, three vaccine trials have yielded promising results, and the first round of Americans could begin to receive shots as early...
NNPA NEWSWIRE — The agreement covers co-development and co-commercialization aimed at accelerating the development of BioNTech’s potential first-in-class COVID-19 mRNA vaccine program, BNT162, which is expected...
NNPA NEWSWIRE — As you may have heard, my team at Pfizer recently experienced a significant disappointment. Our phase 3 trial for rivipansel, a potential treatment...
NNPA NEWSWIRE — “I want people who are going to be able to tell it straight. People who will assess a situation and then be able...
NNPA NEWSWIRE — "If we are going to prepare our country's youth for their future properly, we must ensure that we are giving them the fundamental...
NNPA NEWSWIRE — Marie Ojiambo, who graduated from St. John’s University’s College of Pharmacy and Health Sciences in New York and who specializes in pre-clinical Pharmaceutical...
ROLLINGOUT.COM — Women of Power Summit is one of the top business events in America.
NNPA NEWSWIRE — Her Excellency, Dr. Arikana Chihombori-Quao, the African Union Ambassador to the United States, also appeared at the conference where she and Jamaican Tourist...
NNPA NEWSWIRE — Research indicates that as many as 3 million Americans carry the sickle cell trait, primarily impacting African Americans. In fact, nearly 1 in...
(Tech Times) – Pfizer’s breast cancer drug Ibrance shows favorable clinical trial after facing delays due to efficacy issues. Ibrance is also well-known as palbociclib...